Compound Detail

CHEMBL5407763

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(C(=O)OCc3cn(CC4CN(c5ccc(N6CCOCC6)c(F)c5)C(=O)O4)nn3)CCC[C@]21C

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL5407763
Phase	Preclinical
Structure Type	MOL
InChI Key	ULTFWYBZFZQJLK-QBHHZSOBSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

659.8

MW (Da)

6.16

ALogP

HBA

HBD

99.0

PSA (Å²)

0.27

QED

Ro5 Violations

Rot. Bonds

Availability	Unknown
Chirality	Unknown

First in Class Prodrug

IC50 4 meas. best 4.58

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
MGC-803 CHEMBL3706566	IC50	4.58	4.58	26110.0	1
HepG2 CHEMBL395	IC50	4.54	4.54	28680.0	1
HeLa CHEMBL399	IC50	4.44	4.44	36560.0	1
T-24 CHEMBL614774	IC50	4.2	4.2	63620.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
MGC-803	IC50	=	26110.0	nM	4.58	Anticancer activity against human MGC-803 cells assessed as inhibition of cell g...	38389893
HepG2	IC50	=	28680.0	nM	4.54	Anticancer activity against human HepG2 cells assessed as inhibition of cell gro...	38389893
HeLa	IC50	=	36560.0	nM	4.44	Anticancer activity against human HeLa cells assessed as inhibition of cell grow...	38389893
T-24	IC50	=	63620.0	nM	4.2	Anticancer activity against human T-24 cells assessed as inhibition of cell grow...	38389893

PubMed	DOI	Target Context	# Activities
38389893	10.1039/d3md00550j	HeLa	1
38389893	10.1039/d3md00550j	HepG2	1
38389893	10.1039/d3md00550j	MGC-803	1
38389893	10.1039/d3md00550j	T-24	1
38389893	10.1039/d3md00550j	L02	1

Data from ChEMBL 36 via Core Engine